前往化源商城

HlyU inhibitor CM14

更新时间:2024-11-29 21:05:57

HlyU inhibitor CM14结构式
HlyU inhibitor CM14结构式
品牌特惠专场
常用名 HlyU inhibitor CM14 英文名 HlyU inhibitor CM14
CAS号 588678-13-1 分子量 345.371
密度 1.5±0.1 g/cm3 沸点 N/A
分子式 C20H11NO3S 熔点 N/A
MSDS N/A 闪点 N/A

 HlyU inhibitor CM14用途


HlyU抑制剂CM14(1025E12)是转录调节因子HlyU活性的特异性小分子抑制剂,EC50为30.97 uM,通过共价修饰Cys30抑制HlyU与靶DNA的结合;降低创伤弧菌中毒力基因的HlyU依赖性表达。除了减少人红细胞的溶血而不影响细菌生长或引发宿主细胞死亡;还降低创伤弧菌中毒力基因的HlyU依赖性表达,降低其他弧菌物种的各种毒力基因的表达,从而减弱它们的毒力表型。

 HlyU inhibitor CM14名称

英文名 N-(4-Oxo-4H-thieno[3,4-c]chromen-3-yl)-3-phenyl-2-propynamide
英文别名 更多

 HlyU inhibitor CM14生物活性

描述 HlyU抑制剂CM14(1025E12)是转录调节因子HlyU活性的特异性小分子抑制剂,EC50为30.97 uM,通过共价修饰Cys30抑制HlyU与靶DNA的结合;降低创伤弧菌中毒力基因的HlyU依赖性表达。除了减少人红细胞的溶血而不影响细菌生长或引发宿主细胞死亡;还降低创伤弧菌中毒力基因的HlyU依赖性表达,降低其他弧菌物种的各种毒力基因的表达,从而减弱它们的毒力表型。
参考文献 References 1. Lee ZW, et al. Sci Rep. 2019 Mar 13;9(1):4346. doi: 10.1038/s41598-019-39554-y. View Related Products by Target Other Targets

 HlyU inhibitor CM14物理化学性质

密度 1.5±0.1 g/cm3
分子式 C20H11NO3S
分子量 345.371
精确质量 345.045959
LogP 6.22
折射率 1.731

 HlyU inhibitor CM14英文别名

MFCD03943922
2-Propynamide, N-(4-oxo-4H-thieno[3,4-c][1]benzopyran-3-yl)-3-phenyl-
N-(4-Oxo-4H-thieno[3,4-c]chromen-3-yl)-3-phenyl-2-propynamide
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:

查看所有供应商和价格请点击:

HlyU inhibitor CM14生产厂家

HlyU inhibitor CM14价格

相关化合物: 更多...
PI3Kα inhibitor 1
1235449-52-1
BCL6 inhibitor 8c
2130878-25-8
CHK1 inhibitor
2097938-64-0
JNK INHIBITOR II, NEGATIVE CONTROL
54642-23-8
Bax inhibitor peptide P5
579492-83-4
ATX inhibitor 7
1646784-47-5
CPA inhibitor
223532-02-3
AKR1C3 Inhibitor 5f
1275482-57-9
Smac inhibitor 1
847256-33-1
Copper, [3,5-bis(1,1-dimethylethyl)-2-(hydroxy-I masculineO)benzaldehydato-I masculineO][2-[[[2-(dimethylamino-I masculineN)ethyl]imino-I masculineN]methyl]-4,6-bis(1,1-dimethylethyl)phenolato-I masculineO]-, (SP-5-14)-
494834-28-5
Nickel, [(I+/-R,,I(2)R,4R)-I(2)-methyl-I,2-dioxo-4-phenyl-I+/--[[phenyl[2-[[(2-pyridinyl-I masculineN)carbonyl]amino-I masculineN]phenyl]methylene]amino-I masculineN]-3-oxazolidinepentanoato(2-)-I masculineO3]-, (SP-4-4)-
264921-98-4
Cobalt, bis(N,N-dimethyl-1,3-propanediamine-Na(2))[2,3,9,10-tetrahydro-29H,31H-dibenzo[b,g]bis[1,4]dithiino[2,3-l:2a(2),3a(2)-q]porphyrazinato(2-)-N29,N30,N31,N32]-, (OC-6-24)-
85006-35-5
Isoquinolinium, 2-[[7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, inner salt, [6R-[6I+/-,7I(2)(Z)]]-
86070-93-1
(SP-4-2)-(6,7,14,15-Tetrahydro-7,8,13,14-tetramethyl-6,10,11,15-tetraphenyldipyrazolo[3,4-b:4a(2),3a(2)-h][1,4,7,10]benzotetraazacyclododecine-I masculineN5,I masculineN9,I masculineN12,I masculineN16)nickel(2+)
795260-71-8
methyl (2R)-3-[[3-(3-chloro-4-methoxyphenyl)-2-[[(E)-4-[(2S,3R,4R,5S)-4-hydroxy-3-methyl-5-phenyloxolan-2-yl]but-2-enoyl]amino]propanoyl]amino]-2-methylpropanoate
168482-34-6
(2Z)-4-[3-[[4-[[[3,4-Dihydro-5-(1-methylethyl)-2,4-dioxo-6-(phenylmethyl)-1(2H)-pyrimidinyl]methoxy]methyl]phenyl]methyl]phenyl]-2-hydroxy-4-oxo-2-butenoic acid
1237521-65-1
rel-(3E,5E,7R,8S,9Z,11E,13Z,15E,17Z,19R)-8-[(2-Amino-2-deoxy-I(2)-L-xylo-pentopyranosyl)oxy]-7-hydroxy-7,19-dimethylazacycloeicosa-3,5,9,11,13,15,17-heptaen-2-one
1311284-73-7
21H,23H-Porphine-7-propanoic acid, 13,18-diethyl-17-formyl-7,8-dihydro-3-(methoxycarbonyl)-5-(2-methoxy-2-oxoethyl)-2,8,12-trimethyl-, methyl ester, (7S,8S)-
55968-24-6
Chromium, triaqua[3-[[4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-(oxo-I masculineO)-1H-pyrazol-4-yl]azo-I masculineN1]-4-(hydroxy-I masculineO)-5-nitrobenzenesulfonato(3-)]-, (OC-6-24)-
118578-35-1